In the general US population, the prevalence of diabetes in adults is 9.3%, with the lowest prevalence in young adults and the greatest disease burden in the elderly ( 5 ) . However, the risk for DM in those who have CP is much higher than the general population. Th e prevalence of DM in CP has been estimated anywhere between 25 and 80% ( 6 ) . Increasing age, pancreatic calcifi cations, and prior pancreatic surgery have emerged as factors potentially conveying a higher risk for DM (7) (8) (9) (10) . However, most studies have been small or enroll heavily from a selective CP population such as alcoholic pancreatitis ( 7 ) or hereditary pancreatitis ( 8, 9 ) . Although some features of pancreatitis and treatments have been considered, standard diabetes risk factors such as obesity and family history of diabetes are largely unexplored.
For the fi rst time, we assessed both patient and disease characteristics associated with DM in a diverse cohort of adults with CP of all etiologies enrolled in the multi-center North American Pancreatitis 2 (NAPS2) studies, to determine which risk factors are associated with higher risk of DM. Expanding on existing studies, we added traditional diabetes risk factors such as body mass index (BMI) and family history to the analysis, incorporating both traditional risk factors for insulin resistance and pancreatogenic diabetes.
METHODS

NAPS2 cohort
Patients ( n =1,171) with CP were prospectively enrolled in this cross-sectional study at 26 US Centers participating in the NAPS2 Program, consisting of the original NAPS2, NAPS2 continuation and validation (NAPS2-CV), and NAPS2 Ancillary studies, between 2000 and 2014. Th e NAPS group conducted three sequential studies (NAPS 2, NAPS2-CV, NAPS2 Ancillary study) to prospectively ascertain patients with recurrent acute pancreatitis, CP, and controls (related, family, and unrelated) subjects with an overarching goal to understand the role of genetic and environmental factors in the susceptibility and progression of pancreatitis. NAPS2 represents the original study cohort and NAPS2-CV the validation cohort. As the proportion of blacks in these two studies were few (7% and 8%, respectively), the NAPS2 AS study was undertaken to specifi cally recruit African American subjects. Detailed methodology of the NAPS2 studies has been published (11) (12) (13) .
Patients were enrolled if they had CP, defi ned as previously described based on the following: the presence of characteristic changes on abdominal imaging studies (computerized tomography scan, magnetic resonance imaging/magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography (Cambridge classifi cation), or endoscopic ultrasound (the presence of ≥5 fi ndings or the presence of calcifi cations)) or histology. Controls and patients with recurrent acute pancreatitis but without defi nitive morphologic changes of CP enrolled in the NAPS2 studies were not considered for inclusion in this analysis. Th e study protocol was reviewed and approved by the Institutional Review Boards of all participating centers. Informed consent was obtained from participants.
Data collection
Detailed methodology and data collection procedures for the NAPS2 studies have been previously described (11) (12) (13) and included cross-sectional collection of comprehensive health questionnaires obtained from both the participant and the treating gastrointestinal specialist. Relevant portions of the questionnaires are provided in Supplementary Information S1 online. Th e participant questionnaire focused on collection of demographics, personal and family history, and environmental exposures. Th e physician component included sections on acute and CP history, including pancreatitis etiology, medical and surgical therapies, and other pertinent medical history. Questionnaires were completed by patients with assistance of a trained research coordinator and physicians in a cross-sectional assessment. Parameters assessed for this analysis included: patient demographics, social history including smoking and alcohol use, pain experience, disability or unemployment from pancreatitis-related pain, family history including diabetes in fi rst-and second-degree relatives, physician-defi ned etiology of CP, treatments administered for CP, the presence of diabetes, age at onset of diabetes, if known, and medications taken for diabetes where applicable. Diabetes was stratifi ed based on time of diagnosis as pre-existing diabetes when diabetes was diagnosed >2 years before CP onset, concurrent diabetes when diabetes was diagnosed within 2 years before CP diagnosis, and diabetes aft er CP when the diagnosis of diabetes was made aft er the CP diagnosis. Exocrine insuffi ciency was defi ned based on a physician-reported diagnosis of pancreatic exocrine insuffi ciency. Patients were classifi ed as having diabetes or not having diabetes, for the purposes of this study based on the physician questionnaire response. Information on patients' selfreported pain experience in the year preceding study enrollment is presented only from the NAPS2-CV and NAPS2 Ancillary studies. Th e reason for this choice was the lack of a leading question on the presence of pain (yes/no) before choosing the severity or temporal nature of pain experience in the original NAPS2 study. Data on the type and temporal nature of pain medication use was also limited to the NAPS2-CV and NAPS2 Ancillary studies, where physicians were specifi cally asked to provide this information.
Statistical analyses
Patient demographics and disease characteristics were compared for CP patients with diabetes and without diabetes using a t -test for continuous variables or a Fisher's test for categorical variables. Logistic regression was performed to assess the variables associated with diabetes diagnosis in a multivariable model. Backwards model selection was used. Demographic and morphological variables that were signifi cant in the univariable analysis were included and removed one at a time according to their significance level (Wald's test) until a fi nal model was reached with only signifi cant variables remaining. Gender was borderline significant in the fi nal model and was included. Odds ratios (ORs) and 95% confi dence intervals (CIs) were generated for factors included in the fi nal model. An interaction term between BMI and exocrine insuffi ciency was added to the fi nal model, to test whether the relation between BMI and DM diff ered based on
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exocrine insuffi ciency.Th e fi nal logistic regression model included 1,076 of the 1,171 with complete data for all variables of interest. A sensitivity analysis was performed by excluding 37 patients with a discrepant diabetes status based on the patient and physician questionnaires (patient reported diabetes but physician reported no diabetes). Two subset analyses were performed using the variables of the fi nal logistic model. Th e fi rst included only those DM patients with DM diagnosis prior to CP diagnosis. Th e variable duration of CP was excluded from this model, as DM diagnosis occurred before CP diagnosis. Th e second included DM patients with DM diagnosis aft er CP diagnosis. Data analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
Diabetes prevalence, demographics, and treatment
Among 1171 patients in the NAPS2 patient database with physician ascertainment of current diabetes status, 383 participants had a diagnosis of DM (33%), whereas 788 (67%) were not diabetic. Participants with diabetes were older and had an older age at pancreatitis onset (age at fi rst attack of acute pancreatitis, CP symptoms, or diagnosis, whichever is earlier), longer duration of disease, higher BMI, and lower physical component summary score on the Short Form-12 ( Table 1 , P <0.007 for all). Diabetics were also more likely to be of black race ( P =0.02), to be overweight or obese by BMI ( P <0.0001), and to have a family history of diabetes in a fi rst-degree relative ( P =0.0005). Of those participants with diabetes, 248 (65%) were treated with insulin, 136 (36%) were treated with oral anti-diabetic agents (oral agents alone in 97, both oral agents and insulin in 39), and 38 (9%) were untreated with pharmacologic therapies.
Th e prevalence of diabetes in our cohort increased with increasing age at enrollment ( Figure 1 ). Patients with diabetes had a median age of 49 (37, 56) years at the time of diabetes diagnosis. Although most were diagnosed in adulthood, 11 patients (0.9% of cohort) had childhood-onset diabetes (age of onset <20 years, range 9-16 years), of whom 3 had CP before diabetes onset and the remaining 8 presented with CP symptoms later.
When duration between pancreatitis diagnosis and diabetes onset were known ( n =221), 63 participants (29%) had CP diagnosed before the diagnosis of diabetes, 67 (30%) had diabetes aft er CP was diagnosed, and 91 (41%) were diagnosed with diabetes and CP concurrently. For those participants with pancreatitis diagnosis before diabetes diagnosis, pancreatitis diagnosis preceded diabetes by a median of 3.0 (1.0, 7.0) years.
Disease characteristics, diabetes status, and therapies
Participants with diabetes were more likely to have pancreatitis attributed to hyperlipidemia (3.4% vs. 0.4%, P <0.0001) as an etiology by the enrolling physician ( Table 2 ). However, other etiologies of CP did not diff er between diabetic CP and nondiabetic CP patients. With regards to pancreas morphology, the following imaging features were reported more frequently in diabetics vs. non-diabetics: calcifi cations (63% vs. 54%, P =0.002), atrophy (44% vs. 32%, P <0.0001), and although pancreatic duct and common bile duct strictures and dilatation did not diff er by diabetes status. Pancreatic exocrine insuffi ciency was more common when diabetes was also present (52% of diabetics and 30% of non-diabetics had exocrine insuffi ciency, P <0.0001). Exocrine insuffi ciency conveyed an elevated risk for diabetes across all categories of BMI ( Figure 2 ).
Th ose participants with diabetes were similar to non-diabetics in pain character (intermittent/chronic), pain severity, and need for opioid analgesics. Pancreatic ductal stent placement was less common in diabetic patients ( P =0.003), whereas pancreatic surgery was more common in the patients with diabetes (26.9% of diabetics had prior pancreas surgery vs. 16.9% of non-diabetics, P <0.0001); pancreas resection procedures were over twice as common in the DM vs. no DM group, whereas drainage procedures were increased 1.5-fold in the DM group ( Table 3 ). Cholecystectomy was similar between groups.
Th e proportion of patients who reported disability or unemployment due to pain from pancreatitis was high and similar in both groups: 27% of diabetic CP and 24% of nondiabetic CP participants reported having disability/unemployment ( P =0.28).
Multivariable regression analysis risk factors conveying increased OR for diabetes
Logistic regression modeling was performed to assess variables associated with diabetes diagnosis. Th e ORs obtained for risk of diabetes in CP patients for signifi cant risk factors is summarized in Table 4 . Odds of diabetes diagnosis in CP increased with increasing age of pancreatitis symptom onset, duration of disease, BMI category of overweight or obese, positive family history in fi rst degree relative, pancreatic calcifi cations, prior pancreas surgery, and exocrine insuffi ciency. Th e most notable risk factors for diabetes included obesity by BMI ≥30 kg m −2 vs. normal BMI (OR 2.8, 95% CI 1.9, 4.2), exocrine insuffi ciency (OR 2.4, 95% CI 1.8, 3.2).
An additional interaction term for BMI category and exocrine insuffi ciency added to the fi nal model, to test whether the eff ect of BMI on diabetes diff ered based on the presence of exocrine insuffi ciency. Th is interaction term was insignifi cant ( P =0.576). In other words, overweight and obese BMI category increased the risk of diabetes and exocrine insuffi ciency increased the risk of diabetes, but these two risk factors were independent and additive.
Th e association of BMI and family history was strongest in the subset of patients who had diabetes diagnosed before the diagnosis of CP. In this group of patients, obesity by BMI vs. normal BMI conveyed an OR of 3.3 (95% CI 1.59, 6.97) and positive family history of diabetes with an OR of 1.69 (95% CI 0.99, 2.88) for the presence of diabetes. In contrast, in the subset of patients diagnosed with diabetes aft er CP diagnosis, these associations lost both strength of association and statistical signifi cance: OR Table 5 uses information from the logistic regression model to illustrate the incremental role of the traditional risk factors above and beyond the diseases-related attributes on the probability of diabetes in a representative 50-year-old male with a 5-year duration of disease-the probability of diabetes in a self-reported heavy or very-heavy male drinker during the maximum drinking period in life with normal weight, no family history, no calcifi cations, exocrine insuffi ciency, or pancreatic surgery is 15%, which increases to 42% in the presence of being obese and with a family history, to 74% in the presence of calcifi cations and exocrine insuffi ciency, and 83% if the patient also had pancreatic surgery. For comparison, the risk for DM in an average 50-year-old male with the US population is about 12% ( 5 ). 
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regression modeling, excluding these 37 participants. Th e results without these 37 individuals were essentially unchanged.
DISCUSSION
DM is a long-recognized complication of CP, resulting from progressive pancreatic fi brosis with reduced β -cell mass and impaired insulin secretion. In this large North American cohort of patients with CP, fully one-third of participants with CP had DM. Th is was progressive with age of enrollment, with ~18% of those participants <40 years of age aff ected, increasing to 35->40% aff ected above the age of 40 years. Yet, at any age, this risk was high when compared with the general population risk in the United States ( 5 ). Key pancreatitis disease factors such as morphologically more severe disease, exocrine insuffi ciency, and prior pancreatic surgery increased the odds for diabetes, but so did traditional risk factors for type 2 diabetes including obesity and family history of diabetes. Similar to our fi ndings, pancreatic calcifi cations, pancreatic surgeries, and pancreatic exocrine insuffi ciency have all been previously associated with increased risk for development of DM ( 7, 14 ) . When studied with detailed metabolic and digestive phenotyping, in patients with advanced CP, lower C-peptide levels stimulated by oral glucose and intravenous secretagogues correlate with exocrine insuffi ciency defi ned by lower measured amylase and lipase output. Th is, as well as clinical observations of increased As there were 37 cases where patients self-reported DM, while the physician did not report DM for the same individual, we performed a sensitivity analysis by repeating this multilinear logistic Exocrine insufficient Figure 2 . Prevalence of diabetes by body mass index (BMI) category (at study enrollment) and the presence or absence of exocrine insuffi ciency. Percentage of participants with diabetes is shown in the fi gure, from data from 117 underweight ( n =54 exocrine insuffi cient), 556 normal weight ( n =209 exocrine insuffi cient), 309 overweight ( n =106 exocrine insufficient), and 177 ( n =61 exocrine insuffi cient).
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prevalence of DM with exocrine insuffi cient CP, support the postulated mechanism of progressive fi brosis of the pancreas damaging both the acinar and islet components of the pancreas ( 14 ) . In our population, exocrine insuffi ciency was a risk factor for diabetes in all categories of BMI-exocrine insuffi ciency was diagnosed in a signifi cant proportion of patients in all categories of BMI (underweight, normal weight, overweight, and obese) and increased the risk for diabetes within each subgroup. With regards to other disease morphology and treatments, Malka et al. ( 7 ) previously reported a two-to threefold increased risk of DM with pancreatic calcifi cations and when distal pancreatectomy was performed in patients with primarily alcoholic-mediated CP. Importantly, our fi ndings validate these observations in a larger North American cohort with diverse causes of CP. Th e most common form of diabetes in the United States is type 2 DM-accounting for the majority of the 9.3% of adults who have DM in the United States ( 5 ). Type 2 DM is characterized by insulin resistance with a relative beta cell failure in that the pancreatic β -cells are unable to increase insulin secretion sufficiently to overcome insulin resistance ( 15 ) . Type 2 DM is more common in certain racial minority populations, obese individuals, and those with a family history of diabetes. In contrast to previous studies where traditional T2DM risk factors were not a focus, we identifi ed a substantial increase in the odds of diabetes in our CP patients when obesity (nearly threefold odds of DM), overweight status (1.6-fold increase), or positive family history of DM (1.5-fold increased odds of DM) were present. In the multivariate model, obesity was actually a stronger risk factors for DM than the pancreatic disease features of calcifi cations, prior surgery, or exocrine insuffi ciency. Th is association was particularly driven by the participants who were diagnosed with diabetes before CP diagnosis, suggesting a stronger tendency towards a 'type 2 phenotype' when diabetes is diagnosed early; however, calcifi cations and exocrine insuffi ciency were still strongly associated with DM in these patients who had diabetes prior to the diagnosis of CP, suggesting exocrine parenchymal disease as an additive risk factor. Although Black race was also more frequent in DM, this did not emerge as a signifi cant variable in the multivariable analysis. We postulate that ERCP, endoscopic retrograde cholangiopancreatography; NAPS2-AS, North American Pancreatitis study 2 Ancillary study; NAPS2-CV, North American Pancreatitis study 2 continuation and validation study. a Information on pain experience and pain medication use per physician report is shown from the NAPS2-CV and NAPS2-AS studies only-relevant sample sizes werediabetics ( n =244) and non-diabetics ( n =405).
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resistance or genetic impairments in β -cell function. Th is 'double hit' process may be particularly important in those diagnosed with diabetes earlier, whereas later diabetes may be largely driven by the pancreas parenchymal injury from the CP process itself. As might be anticipated, the patients who were diabetic were, on average, older and with a longer duration of disease. Th is is consistent with previous literature, suggesting that prevalence of diabetes increases with increased duration of disease ( 16 ) . Of note, the presumed etiology of disease was not an important factor in predicting risk for DM in our patient cohort. Hyperlipidemia was reported more frequently as a primary suspected cause for pancreatitis in those with DM, as might be expected due to the relationship between hyperlipidemia and DM ( 17, 18 ) , but this was a rare etiology for CP. Th e more common etiologies of alcohol use, idiopathic CP, and genetic disease were similarly distributed among CP patients with and without DM.
Surprisingly, in multivariate regression modeling, we found a lower odds for diabetes in participants identifi ed as low to moderate alcohol drinkers compared to alcohol abstainers (OR for diabetes of 0.60). Th e reason for this association is unclear. In type 2 diabetes research, light consumption of red wine (one glass per day) has been associated with a signifi cant reduction in fasting glucose compared with placebo ( 19 ) , and in healthy controls a shortterm infusion of alcohol to a blood alcohol level of 0.08 suppresses gluconeogenesis and endogenous glucose production during conditions of hyperglycemia ( 20 ) , suggesting theoretical potential for light alcohol use to lower blood glucose. Although this is speculative, it is consistent with literature in type 2 diabetes, suggesting a potential protective eff ect of light to moderate alcohol consumprisk factors for type 2 DM could increase or hasten the presentation of type 3c DM (pancreatogenous diabetes), due to a 'doublehit' of impaired pancreatic beta cell mass from CP plus insulin A novel aspect to the NAPS2 cohort is that we collected qualityof-life scores on patients by the short-form 12 as part of the patient questionnaires ( 22 ) . In univariable analysis, on the Short Form -12, the mean physical component summary score was slightly lower in those with DM, suggesting that the combination of DM+CP adds greater physical disease burden than CP alone. However, in a recent analysis of factors determining quality of life in CP patients (paper under review), DM was not a signifi cant factor in a multivariable model. Moreover, the patients with CP and DM were not on disability coverage any more oft en than CP alone, perhaps refl ecting that the rate of disability in CP was already overall high (about one in every four participants).
Although we postulate that obesity and genetic risk, refl ected by a family history of DM, are risk factors for developing type 3c DM as well, a subset of our population may simply have classic type 2 DM since type 2 is present in about 9% of the general US population. Within the limitations of this epidemiologic cohort, we do not have any tests to distinguish type 2 DM from type 3c DM from 'double/ overlapping' type 2/ type 3c DM. We also did not assess whether beta cell autoimmunity (type 1 diabetes) was a contributor to diabetes development in this cohort; however, interestingly, 1 in every 106 study participants was diagnosed with DM at age <21 years, fourfold higher than the expected rate of childhood onset diabetes of 1 in every 418 children in the United States in 2009 ( 23 ), even though most were not yet diagnosed with CP at time of childhood onset DM. Future studies-including those emerging from the Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) research consortium-will be necessary to better defi ne diagnostic protocols to accurately classify type 3c vs. type 2 DM, and to explore whether markers of β -cell autoimmunity are more prevalent in those with CP, as has been reported recently for cystic fi brosis-related diabetes ( 24 ) , and whether markers such as pancreatic polypeptide can adequately distinguish true type 3c vs. classic type 2 DM in those with CP.
Our cohort is also limited by the cross-sectional nature of the analyses to identify associations with DM-further large-scale longitudinal studies will be needed to confi rm these risk factors, determine more specifi cally the timing of onset of disease, and relation to CP disease and duration. As delayed diagnoses are possible for both CP and diabetes, the dates of diagnosis that were provided by the physician may not accurately refl ect the time course of actual CP and diabetes onset, thus confounding our associations. Th e prevalence of DM in our cohort may be an underestimation as formal testing for diabetes was not a requirement as part of the NAPS2 study enrollment. In addition, recall bias may occur with assessment of family history of diabetes or hyperlipidemia as a cause of CP in those who are obese or already diabetic (i.e., have health complications that may be associated with these features). Likewise, pancreatic exocrine insuffi ciency (a risk factor for higher odds DM) was defi ned by physician report and thus it is possible that exocrine insuffi ciency was over or underdiagnosed in the cohort.
Overall, our results support the previously cited high rate of DM in CP, much higher than the general population. Previously suspected risk factors for DM such as exocrine insuffi ciency, calcifi cations, and pancreas surgery were observed in this large diverse cohort. However, we identifi ed traditional 'type 2 DM' risk factors of obesity and family history as equally contributing to the odds of developing DM in the context of CP, especially for those diagnosed with diabetes early. 
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Study Highlights
WHAT IS CURRENT KNOWLEDGE?
✓ Patients with chronic pancreatitis (CP) are at high risk for developing diabetes mellitus (DM).
✓ Pancreatic exocrine insuffi ciency, pancreatic surgery, and pancreatic calcifi cations have been associated with higher risk for DM, but such studies are often in select populations (alcoholic disease, or hereditary disease).
WHAT IS NEW HERE
✓ Patients (1,171) with CP with diverse causes for CP, seen at 26 pancreatic care centers in the United States were studied for prevalence of DM and risk factors for DM.
✓ Pancreatic exocrine insuffi ciency, pancreatic calcifi cations, and pancreatic surgery were risk factors for DM.
✓ This is the fi rst study to identify traditional 'type 2' DM risk factors of obesity and positive family history of DM associated with risk for DM in CP. However, the impact of obesity and family history is strongest when diabetes precedes the diagnosis of CP.
✓ A 'double hit' of pancreatic damage from CP and traditional type 2 DM risk factors may increase the risk for DM in the setting of CP.
